C86.51 is a new billable/specific diagnosis code introduced in the 2025 ICD-10-CM used to classify the following condition: Angioimmunoblastic T-cell lymphoma, in remission.
Inclusion term
Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD), in remission
Versions
2025
New code